|
Thalidomide (200 mg) |
50-35-1 |
1652500 |
USP |
詳細を見る
|
|
Tetraxetan Related Compound A (25 mg) (2,2′,2-[10-(2-Ethoxy-2-oxoethyl)-1… |
2101625-18-5 |
1652169 |
USP |
詳細を見る
|
|
Tetraxetan (50 mg) |
60239-18-1 |
1652158 |
USP |
詳細を見る
|
|
Tetramethyl Ethylene Diamine (25 mg) (N1,N1,N2,N2-tetramethylethane-1,2-diamine) |
110-18-9 |
1A00400 |
USP |
詳細を見る
|
|
Tetrahydrozoline Related Compound E (25 mg) (N-(2-Aminoethyl)-1,2,3,4-tetrahydr… |
84460-89-9 |
1652056 |
USP |
詳細を見る
|
|
Tetrahydrozoline Related Compound D (25 mg) (2-(Naphthalen-1-yl)-4,5-dihydro-1H… |
13623-57-9 (free base) |
1652045 |
USP |
詳細を見る
|
|
Tetrahydrozoline Related Compound C (25 mg) (1,2,3,4-Tetrahydronaphthalene-1-ca… |
1914-65-4 |
1652034 |
USP |
詳細を見る
|
|
Tetrahydrozoline Related Compound B (25 mg) (2-(1,2,3,4-Tetrahydronaphthalen-1-… |
945389-41-3 |
1652023 |
USP |
詳細を見る
|
|
Tetrahydrozoline Related Compound A (50 mg) (1,2,3,4-Tetrahydronaphthalene-1-ca… |
56536-96-0 |
1652012 |
USP |
詳細を見る
|
|
Tetrahydrozoline Hydrochloride (200 mg) |
522-48-5 |
1652001 |
USP |
詳細を見る
|
